Pathway ID |
Pathway Name |
p-Value |
Adjusted p-Value |
Enriched Genes |
hsa00910 |
Nitrogen metabolism_Homo sapiens_hsa00910 |
6.098E-08 |
1.403E-06 |
CA12; CA7; CA9 |
hsa05134 |
Legionellosis_Homo sapiens_hsa05134 |
3.295E-04 |
3.521E-03 |
CASP7; CASP1 |
hsa00830 |
Retinol metabolism_Homo sapiens_hsa00830 |
4.602E-04 |
3.521E-03 |
CYP1A2; ALDH1A1 |
hsa05133 |
Pertussis_Homo sapiens_hsa05133 |
6.124E-04 |
3.521E-03 |
CASP7; CASP1 |
hsa05010 |
Alzheimer's disease_Homo sapiens_hsa05010 |
3.020E-03 |
1.158E-02 |
CASP7; HSD17B10 |
hsa01100 |
Metabolic pathways_Homo sapiens_hsa01100 |
2.049E-02 |
4.859E-02 |
CYP1A2; ALDH1A1; HSD17B10 |
hsa00380 |
Tryptophan metabolism_Homo sapiens_hsa00380 |
1.983E-02 |
4.859E-02 |
CYP1A2 |
hsa00280 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 |
2.375E-02 |
4.859E-02 |
HSD17B10 |
hsa00591 |
Linoleic acid metabolism_Homo sapiens_hsa00591 |
1.441E-02 |
4.734E-02 |
CYP1A2 |
hsa05014 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 |
2.521E-02 |
4.859E-02 |
CASP1 |
hsa04621 |
NOD-like receptor signaling pathway_Homo sapiens_hsa04621 |
2.814E-02 |
4.859E-02 |
CASP1 |
hsa00982 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 |
3.398E-02 |
4.859E-02 |
CYP1A2 |
hsa00140 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 |
2.863E-02 |
4.859E-02 |
CYP1A2 |
hsa04623 |
Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 |
3.155E-02 |
4.859E-02 |
CASP1 |
hsa00980 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 |
3.591E-02 |
4.859E-02 |
CYP1A2 |
hsa04976 |
Bile secretion_Homo sapiens_hsa04976 |
3.495E-02 |
4.859E-02 |
NR1H4 |
hsa00232 |
Caffeine metabolism_Homo sapiens_hsa00232 |
2.498E-03 |
1.149E-02 |
CYP1A2 |